![]() Triclabendazole sulfoxide structure
|
Common Name | Triclabendazole sulfoxide | ||
---|---|---|---|---|
CAS Number | 100648-13-3 | Molecular Weight | 375.65700 | |
Density | 1.69 | Boiling Point | 547.6ºC at 760 mmHg | |
Molecular Formula | C14H9Cl3N2O2S | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 285ºC |
Use of Triclabendazole sulfoxideTriclabendazole sulfoxide (TCBZ-SO) is the main plasma metabolite of Triclabendazole, and exhibits anti-parasite effects. Triclabendazole sulfoxide can inhibit membrane transporter ABCG2/BCRP[1][2]. |
Name | 6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfinyl-1H-benzimidazole |
---|---|
Synonym | More Synonyms |
Description | Triclabendazole sulfoxide (TCBZ-SO) is the main plasma metabolite of Triclabendazole, and exhibits anti-parasite effects. Triclabendazole sulfoxide can inhibit membrane transporter ABCG2/BCRP[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.69 |
---|---|
Boiling Point | 547.6ºC at 760 mmHg |
Molecular Formula | C14H9Cl3N2O2S |
Molecular Weight | 375.65700 |
Flash Point | 285ºC |
Exact Mass | 373.94500 |
PSA | 74.19000 |
LogP | 5.91850 |
Vapour Pressure | 4.81E-12mmHg at 25°C |
Index of Refraction | 1.749 |
Storage condition | 2-8°C |
~93% Triclabendazole... CAS#:100648-13-3 |
Literature: Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), , # 22 p. 3129 - 3134 |
Precursor 1 | |
---|---|
DownStream 0 |
Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole.
Parasitol. Res. 82(4) , 333-9, (1996) The effects of the active sulphoxide metabolite of the fasciolicide triclabendazole (Fasinex, Ciba-Geigy) on the vitelline cells of Fasciola hepatica were determined in vitro by transmission electron ... |
|
Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
Exp. Parasitol. 136 , 14-9, (2014) The flukicidal compound triclabendazole (TCBZ) has a complex metabolic pattern that includes the systemic presence of its sulphoxide (TCBZ.SO) and sulphone (TCBZ.SO2) metabolites, usually recovered fr... |
|
Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole.
Parasitol. Res. 88(4) , 315-25, (2002) The effect of the active sulphoxide metabolite of the fasciolicide triclabendazole on the surface morphology of the tropical liver fluke, Fasciola gigantica, was determined in vitro by scanning electr... |
Tcbz-SX |
Triclabendazole sulfoxide |
1H-Benzimidazole,6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfinyl) |
5-chloro-6-(2,3-dichlorophenoxy)-2-methylsulfinyl-1H-benzimidazole |
triclabendazole sulphoxide |